Neurotrope Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
15,211.70
8,010.40
11,230.60
25,773.50
16,113.20
28,854.20
Total Accounts Receivable
-
-
2.80
-
-
-
Other Current Assets
87.10
97.10
1,489.90
138.70
310.40
603.30
Total Current Assets
15,298.80
8,107.40
12,723.20
25,912.20
16,423.60
29,457.50
Net Property, Plant & Equipment
-
53.60
59.20
55.20
20.70
20.80
Total Assets
15,298.80
8,161.00
12,782.40
25,967.40
16,444.20
29,478.40
ST Debt & Current Portion LT Debt
-
-
10.50
-
-
Accounts Payable
408.40
-
-
-
1,240.00
Other Current Liabilities
-
1,289.20
980.50
2,362.80
318.30
Total Current Liabilities
408.40
1,289.20
991.00
2,362.80
1,558.30
Total Liabilities
408.40
1,289.20
991.00
2,362.80
1,558.30
Common Equity (Total)
5,053.20
11,652.30
23.40
23,604.70
14,886.00
Total Shareholders' Equity
14,890.40
6,871.90
11,791.50
23,604.70
14,886.00
Total Equity
14,890.40
6,871.90
11,791.50
23,604.70
14,886.00
Liabilities & Shareholders' Equity
15,298.80
8,161.00
12,782.40
25,967.40
16,444.20
Preferred Stock (Carrying Value)
19,943.60
18,524.20
11,814.90
-
-
About Neurotrope
View Profile
